The main activity of the Company is producing pharmaceutical products,chemicals and a variety of injectable solutions for human and veterinary use.
The Company was established as a private Company under a registration number 3164 with the name of Shahid Ghazi Tabriz Serum Manufacturing on 10 January 1985.
The Company started its activity on 22 August 1994 .
On 7 January 2003 the Company changed its name to be Shahid Ghazi Pharmaceutical .
On 26 April 1998 the Company changed its legal form to be Public Joint Stock Company .
The Company was registered in Tehran Stock Exchange on 3 October 2015.
then The Company was listed in Iran Fara Bourse on 6 August 2016.
The Company Changed its Year End from on 22 September to 20 March .
The Company is currently increasing its production capacity to 30 million injectable and sterile solutions and 150 million kinds of injectable medicine and sterile injectable injections, in addition to having the largest share in terms of supplying the country with the provision of 32.87 of injectable solution And about 80 of injectable sterile water can be exported to Afghanistan, Turkmenistan, Azerbaijan, Tajikistan, Somalia and Iraq.
Legal Address
Marzdaran Boulevard, Not Far From Yadegar Imam Shomali Bridge, Fereshtegan Street, No 3 - Po.Box 6771-15875
Tehran; Tehran;
Postal Code: 1463813418
Contact Details: Purchase the Shahid Ghazi Pharmaceutical Company Public Joint Stock report to view the information.
Website: http://www.sgco-infusion.com
EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.
Request a demo of the EMIS serviceTo view more information, Request a demonstration of the EMIS service